Oxycodone/naltrexone - Elite Pharmaceuticals
Alternative Names: Abuse resistant oxycodone; ELI-200; ELI-201; ELI-216; Naltrexone/oxycodone - Elite Pharmaceuticals; Oxy-Nal; Oxycodone hydrochloride/Naltrexone - Elite Pharmaceuticals; OxyNal™; SequestOxLatest Information Update: 16 Apr 2021
At a glance
- Originator Elite Pharmaceuticals
- Class Analgesics; Cyclopropanes; Drug withdrawal therapies; Ethers; Ketones; Morphinans; Morphine derivatives; Opioid analgesics; Small molecules
- Mechanism of Action Opioid delta receptor agonists; Opioid kappa receptor agonists; Opioid mu receptor agonists; Opioid receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes - Pain
Highest Development Phases
- Suspended Pain; Postoperative pain